|
Name |
WIN66306
|
Molecular Formula | C41H52N8O9 | |
IUPAC Name* |
9-[hydroxy-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]methyl]-3-(1H-indol-3-ylmethyl)-15-propan-2-yl-1,4,7,10,13,16,19-heptazabicyclo[19.3.0]tetracosane-2,5,8,11,14,17,20-heptone
|
|
SMILES |
CC(C)=CCc1cc(C(O)C2NC(=O)CNC(=O)C(C(C)C)NC(=O)CNC(=O)C3CCCN3C(=O)C(Cc3c[nH]c4ccccc34)NC(=O)CNC2=O)ccc1O
|
|
InChI |
InChI=1S/C41H52N8O9/c1-22(2)11-12-24-16-25(13-14-31(24)50)37(54)36-40(57)45-19-32(51)46-29(17-26-18-42-28-9-6-5-8-27(26)28)41(58)49-15-7-10-30(49)38(55)43-20-33(52)47-35(23(3)4)39(56)44-21-34(53)48-36/h5-6,8-9,11,13-14,16,18,23,29-30,35-37,42,50,54H,7,10,12,15,17,19-21H2,1-4H3,(H,43,55)(H,44,56)(H,45,57)(H,46,51)(H,47,52)(H,48,53)/t29-,30-,35-,36-,37?/m0/s1
|
|
InChIKey |
BNPYZZVTLFIGQT-VUPYCZGQSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 800.91 | ALogp: | 0.1 |
HBD: | 9 | HBA: | 9 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 251.2 | Aromatic Rings: | 5 |
Heavy Atoms: | 58 | QED Weighted: | 0.151 |
Caco-2 Permeability: | -6.267 | MDCK Permeability: | 0.00000135 |
Pgp-inhibitor: | 0.169 | Pgp-substrate: | 0.775 |
Human Intestinal Absorption (HIA): | 0.949 | 20% Bioavailability (F20%): | 0.984 |
30% Bioavailability (F30%): | 0.998 |
Blood-Brain-Barrier Penetration (BBB): | 0.17 | Plasma Protein Binding (PPB): | 74.65% |
Volume Distribution (VD): | 0.52 | Fu: | 20.98% |
CYP1A2-inhibitor: | 0.001 | CYP1A2-substrate: | 0.027 |
CYP2C19-inhibitor: | 0.11 | CYP2C19-substrate: | 0.045 |
CYP2C9-inhibitor: | 0.26 | CYP2C9-substrate: | 0.146 |
CYP2D6-inhibitor: | 0.006 | CYP2D6-substrate: | 0.088 |
CYP3A4-inhibitor: | 0.548 | CYP3A4-substrate: | 0.034 |
Clearance (CL): | 1.605 | Half-life (T1/2): | 0.791 |
hERG Blockers: | 0.071 | Human Hepatotoxicity (H-HT): | 0.772 |
Drug-inuced Liver Injury (DILI): | 0.03 | AMES Toxicity: | 0.004 |
Rat Oral Acute Toxicity: | 0.547 | Maximum Recommended Daily Dose: | 0.438 |
Skin Sensitization: | 0.04 | Carcinogencity: | 0.005 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.002 |
Respiratory Toxicity: | 0.02 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005563 | 0.475 | D09ZIO | 0.429 | ||||
ENC004971 | 0.403 | D0J7XL | 0.330 | ||||
ENC005343 | 0.390 | D0M2YE | 0.329 | ||||
ENC002483 | 0.362 | D0X9PF | 0.318 | ||||
ENC004610 | 0.362 | D07DSQ | 0.307 | ||||
ENC000975 | 0.362 | D02XIY | 0.304 | ||||
ENC001926 | 0.358 | D0E2OU | 0.289 | ||||
ENC002484 | 0.346 | D06WKA | 0.284 | ||||
ENC004432 | 0.343 | D00GNJ | 0.284 | ||||
ENC004435 | 0.342 | D09NNH | 0.273 |